Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321000903> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4321000903 endingPage "263" @default.
- W4321000903 startingPage "256" @default.
- W4321000903 abstract "A comparative analysis of anesthesia use, perioperative morbidity and mortality, capital, and treatment cost of high dose rate versus low dose rate intracavitary brachytherapy for gynecologic malignancy is presented. To assess current anesthesia utilization, application location, and high dose rate afterloader availability for gynecologic brachytherapy in private and academic practices, a nine-question survey was sent to 150 radiotherapy centers in the United States, of which 95 (63%) responded. Of these 95 respondents, 95% used low dose rate brachytherapy, and 18% possessed high dose rate capability. General anesthesia was used in 95% of programs for tandem + ovoid and in 31% for ovoids-only placement. Differences among private and academic practice respondents were minimal. In our institution, a cost comparison for low dose rate therapy (two applications with 3 hospital days per application, operating and recovery room use, spinal anesthesia, radiotherapy) versus high dose rate treatment (five outpatient departmental applications, intravenous anesthesia without an anesthesiologist, radiotherapy) revealed a 244% higher overall charge for low dose rate treatment, primarily due to hospital and operating room expenses. In addition to its ability to save thousands of dollars per intracavitary patient, high dose rate therapy generated a “cost-shift,” increasing radiotherapy departmental billings by 438%. More importantly, perioperative morbidity and mortality in our experience of 500+ high dose rate applications compared favorably with recently reported data using low dose rate intracavitary treatment. Capital investment, maintenance requirements, and depreciation costs for high dose rate capability are reviewed. Application of the defined “revenue-cost ratio” formula demonstrates the importance of high application numbers and consistent reimbursement for parity in high dose rate operation. Logically, inadequate third-party reimbursement (e.g., Medicare) reduces high dose rate parity and threatens the future availability of high dose rate technology." @default.
- W4321000903 created "2023-02-17" @default.
- W4321000903 creator A5004199593 @default.
- W4321000903 creator A5006007220 @default.
- W4321000903 creator A5033061826 @default.
- W4321000903 creator A5040627214 @default.
- W4321000903 creator A5045792423 @default.
- W4321000903 creator A5064564887 @default.
- W4321000903 creator A5083448435 @default.
- W4321000903 date "1993-06-01" @default.
- W4321000903 modified "2023-10-10" @default.
- W4321000903 title "Resource Utilization" @default.
- W4321000903 doi "https://doi.org/10.1097/00000421-199306000-00013" @default.
- W4321000903 hasPublicationYear "1993" @default.
- W4321000903 type Work @default.
- W4321000903 citedByCount "16" @default.
- W4321000903 countsByYear W43210009032012 @default.
- W4321000903 countsByYear W43210009032015 @default.
- W4321000903 countsByYear W43210009032016 @default.
- W4321000903 crossrefType "journal-article" @default.
- W4321000903 hasAuthorship W4321000903A5004199593 @default.
- W4321000903 hasAuthorship W4321000903A5006007220 @default.
- W4321000903 hasAuthorship W4321000903A5033061826 @default.
- W4321000903 hasAuthorship W4321000903A5040627214 @default.
- W4321000903 hasAuthorship W4321000903A5045792423 @default.
- W4321000903 hasAuthorship W4321000903A5064564887 @default.
- W4321000903 hasAuthorship W4321000903A5083448435 @default.
- W4321000903 hasConcept C141071460 @default.
- W4321000903 hasConcept C194828623 @default.
- W4321000903 hasConcept C2777416452 @default.
- W4321000903 hasConcept C31174226 @default.
- W4321000903 hasConcept C42219234 @default.
- W4321000903 hasConcept C509974204 @default.
- W4321000903 hasConcept C71924100 @default.
- W4321000903 hasConceptScore W4321000903C141071460 @default.
- W4321000903 hasConceptScore W4321000903C194828623 @default.
- W4321000903 hasConceptScore W4321000903C2777416452 @default.
- W4321000903 hasConceptScore W4321000903C31174226 @default.
- W4321000903 hasConceptScore W4321000903C42219234 @default.
- W4321000903 hasConceptScore W4321000903C509974204 @default.
- W4321000903 hasConceptScore W4321000903C71924100 @default.
- W4321000903 hasIssue "3" @default.
- W4321000903 hasLocation W43210009031 @default.
- W4321000903 hasOpenAccess W4321000903 @default.
- W4321000903 hasPrimaryLocation W43210009031 @default.
- W4321000903 hasRelatedWork W2091634078 @default.
- W4321000903 hasRelatedWork W2327556405 @default.
- W4321000903 hasRelatedWork W2349210304 @default.
- W4321000903 hasRelatedWork W2352247659 @default.
- W4321000903 hasRelatedWork W2354785620 @default.
- W4321000903 hasRelatedWork W2373658663 @default.
- W4321000903 hasRelatedWork W2375359181 @default.
- W4321000903 hasRelatedWork W2586998360 @default.
- W4321000903 hasRelatedWork W2767618185 @default.
- W4321000903 hasRelatedWork W4324096639 @default.
- W4321000903 hasVolume "16" @default.
- W4321000903 isParatext "false" @default.
- W4321000903 isRetracted "false" @default.
- W4321000903 workType "article" @default.